Влияние недавних изменений в GVP ЕАЭС
January 21, 2025
Inpharmatis opened an official representative office in Tashkent
The office in Uzbekistan will become the regional “hub” of Inpharmatis in Central Asia, noted the company`s CEO Dr. Polina Dombure.
“The pharmaceutical industry of Uzbekistan is developing dynamically, manufacturers are actively introducing innovative solutions both in the production and registration of medicines. Today, enterprises of the world's leading pharmaceutical manufacturers are represented in Uzbekistan, medicines are in demand not only in the domestic market but are also actively exported abroad. The representative office of Inpharmatis in Uzbekistan will become a regional “hub” for Central Asia. We are confident that more than 15 years of experience of Inpharmatis in the countries of the European Union and the CIS will allow our company to make a significant contribution to the development of pharmaceutical production in Uzbekistan,” said Polina Dombure.
Saidamir Sadikov, Head of the Inpharmatis representative office in Tashkent, said that: “The opening of an official representative office in Uzbekistan provides new opportunities for cooperation of Inpharmatis both with state regulatory bodies of the Republic of Uzbekistan and with pharmaceutical manufacturers”.
Inpharmatis considers the most promising areas for a partnership to be the automation of quality management in pharmaceutical production, electronic solutions for regulating access to the pharmaceutical market, GMP audits, and joint projects in the field of Regulatory Affairs and pharmacovigilance.
According to the Ministry of Foreign Trade of Uzbekistan, today there are 152 pharmaceutical enterprises in the country that produce 2,373 names of medicines. There are 8 research institutes and centers. In addition, the only plant in Central Asia is located in Uzbekistan, which specializes in the production of insulin used for the treatment of diabetes mellitus.


Impact of Recent Changes in EAEU GVP
January 21, 2025
Новые правила оплаты регистрации лекарственных средств и медицинских изделий в Узбекистане
December 03, 2024
New Payment Rules for Medicines and Medical Device Registration in Uzbekistan
December 03, 2024
Inpharmatis открыла юридическое лицо в Узбекистане
November 28, 2024
Inpharmatis Opens an LLC Legal Entity in Uzbekistan
November 28, 2024
Полина Домбуре, генеральный директор Inpharmatis Group, выступит спикером на вебинаре, организованном TOPRA
October 16, 2024
Dr. Polina Dombure to Speak at TOPRA Webinar "Navigating Regulatory Changes in Moldova and Ukraine"
October 16, 2024
Полина Домбуре, генеральный директор Inpharmatis Group, примет участие в CPHI Milan 8-10 октября 2024
September 25, 2024
Dr. Polina Dombure, CEO of Inpharmatis Group, will be attending CPHI Milan in 8-10 October 2024
September 25, 2024